Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00487773
Status:
COMPLETED
Last Update Posted:
2010-04-13
First Post:
2007-06-18
Brief Title:
Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma
Sponsor:
Medical University of Lodz
Organization:
Medical University of Lodz
Study Overview
Official Title:
Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma - Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2010-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the trial is to check if inhaled glucocorticosteroids iGCS have influence on bone condition if iGCS increases risk of osteoporosis and bone fraction in children with asthma
Detailed Description:
Asthma is the most prevalent chronic disease of respiratory tract the largest frequency is noticed in children iGCS are the basic group of drugs in asthma because of inflammatory character of disease All iGCS are absorbed to the systemic circulation small amounts despite of local exposition in lungs and possess systemic effects The purpose of trial is to check if iGCS have influence on bone condition if iGCS increases risk of osteoporosis and bone fraction in children with asthma
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None